Amphenol Corporation
NYSE:APHHardware, Equipment & Parts
+$4.29 today
- Market cap
- $188.48B
- Beta
- 1.27
- P/E (TTM)
- 45.4
- EPS (TTM)
- $3.64
- Dividend yield
- 0.50%
Volume 11.98M
Average 9.79M
APH Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Amphenol CorporationNYSE: APH
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0. Over 3 fiscal years it compounded at +26.0% a year.
Context
- Research & development amounted to 2.8% of revenue in FY2025, down 0.2 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 647M USD
- Year-over-year change
- +42.8%
- 4-year CAGR
- +19.5%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 647M | +42.8% |
| FY2024 | 2024-12-31 | 453M | +32.4% |
| FY2023 | 2023-12-31 | 342.2M | +5.7% |
| FY2022 | 2022-12-31 | 323.6M | +1.9% |
| FY2021 | 2021-12-31 | 317.7M | — |
Research & Development vs competitors
How APH compares with its peers on the latest reported figures
- APH's LTM Jun 2026 research & development of $0 is the lowest of the 5 companies compared; the peer median is $522.86M.
- Its year-over-year change of -100.0% is the lowest of 5, against a peer median of +10.8%.
- Research & development amounts to 0.0% of revenue for APH, versus a peer median of 4.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.14B | +2.3% | +2.0% | 6.7% | |
| LTM Jun 2026 | $919M | +15.3% | +10.8% | 4.8% | |
| LTM Jun 2026 | $126.73M | +6.3% | +7.2% | 4.4% | |
| LTM Apr 2026 | $1.77M | +145.2% | — | 2.2% | |
| LTM Jun 2026 | $0 | -100.0% | +26.0% | 0.0% | |
| Peer median (excluding APH) | $522.86M | +10.8% | +7.2% | 4.6% | |
Competitors are the stored peer set for APH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 10.88B | 12.62B | 12.55B | 15.22B | 23.09B |
| Cost of Revenue | 7.47B | 8.59B | 8.47B | 10.08B | 14.5B |
| Gross Profit | 3.4B | 4.03B | 4.08B | 5.14B | 8.6B |
| Gross Margin | 31.3% | 31.9% | 32.5% | 33.8% | 37.2% |
| Research & Development | 317.7M | 323.6M | 342.2M | 453M | 647M |
| Selling, General & Admin | 908.6M | 1.1B | 1.15B | 1.4B | 1.9B |
| Operating Expenses | 1.23B | 1.42B | 1.49B | 1.86B | 2.73B |
| Depreciation & Amortization | 395.6M | 392.9M | 406.4M | 572.5M | 922.4M |
| EBITDA | 2.5B | 2.99B | 3B | 3.8B | 6.97B |
| EBITDA Margin | 23.0% | 23.7% | 23.9% | 25.0% | 30.2% |
| Operating Income | 2.18B | 2.61B | 2.59B | 3.28B | 5.87B |
| Operating Margin | 20.0% | 20.7% | 20.7% | 21.6% | 25.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 115.5M | 128.4M | 139.5M | 217M | 367.8M |
| Other Income / Expenses | (186.3M) | (139.9M) | (139.4M) | (272.4M) | (267.9M) |
| Income Before Tax | 1.99B | 2.47B | 2.45B | 3.01B | 5.6B |
| Pre-Tax Margin | 18.3% | 19.5% | 19.6% | 19.8% | 24.3% |
| Income Tax Expense | 409.1M | 550.6M | 509.3M | 570.3M | 1.3B |
| Net Income | 1.59B | 1.9B | 1.93B | 2.42B | 4.27B |
| Net Margin | 14.6% | 15.1% | 15.4% | 15.9% | 18.5% |
| EPS (Basic) | 0.67 | 0.80 | 0.81 | 1.01 | 1.76 |
| EPS (Diluted) | 0.64 | 0.77 | 0.78 | 0.96 | 1.67 |
| Weighted Avg Shares | 2.39B | 2.38B | 2.39B | 2.41B | 2.44B |
| Weighted Avg Shares (Diluted) | 2.5B | 2.48B | 2.48B | 2.53B | 2.56B |
Amphenol Corporation
NYSE:APH
Intrinsic Alpha fair value
Locked
Current Price
$76.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.